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Intervertebral spaceAbstract Neurofibromatosis is an autosomal dominant disease characterized by widespread effects
on different systems of the body. A 65 year old male who had to undergo surgery on the left thigh
had neurofibromatosis type 1 with extensive neurofibromas all over his body, including the entire
back. Patient was given spinal anaesthesia, at L3–L4 intervertebral space. Successful subarachnoid
block was obtained and the surgery was performed successfully without any untoward complica-
tions.
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Neurofibromatosis is a group of hereditary diseases transmit-
ted in autosomal dominant manner. It has extensive effects
on ectodermal and mesodermal tissue and is the most common
type of neurocutaneous syndromes. On clinical and genetic
grounds, neurofibromatosis has been classified into two
different types – neurofibromatosis type 1 (NF1) and neurofi-
bromatosis type 2 (NF2). Von Recklinghausen disease, also
known as neurofibromatosis 1 (NF1), is characterized bymultiple cafe-au-lait spots in the skin, multiple peripheral
nerve tumors, and a variety of other dysplastic abnormalities
of the skin, nervous system, bones, endocrine organs, and
blood vessels [1]. The birth incidence of NF1 lies between 1
in 2500 and 1 in 3300 and its prevalence in the population is
1 in 5000 [2]. NF2 is defined by the presence of bilateral
vestibular schwannomas. The birth incidence of NF2 lies
between 1 in 33,000 and 1 in 40,000 with a prevalence within
the population of 1 in 210,000 [3]. Both NF1 and NF2 can pre-
sent as a non-generalized form in which only one body part is
affected.
All this requires astute decisions on part of the anaesthesi-
ologist confronted with such a case posted for surgery, as
unique obstacles must be overcome for success.
2. Case report
A 65 year old male with body weight 58 kg and height 166 cm
presented with a fungating ulcer for the past two months
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present on the anterior aspect of his left thigh.
In the preoperative laboratory assessment all the investiga-
tions were within normal range. A pulmonary Function Test
was done which was within normal range. A cranial and spinal
MRI was advised to rule out central nervous system involve-
ment, which showed no abnormality (Fig. 1).
On physical examination, the patient’s entire body was cov-
ered with nodules of different sizes (Fig. 2). Oral examination
revealed lesions on the tongue. To rule out deeper involvement
of the airways, indirect laryngoscopic examination was done,
the results of which were normal. The rest of the physical
examination was normal. There was no associated deformity
of the spine. There was no history of any other associated
comorbidity. The patient consented for regional anaesthesia
only, so it was decided to conduct the case under spinal anaes-
thesia. A written informed consent was obtained. On arrival in
the operating room, an 18-gauge intravenous line was secured
and all the standard monitors were attached. 500 ml lactated
ringer’s solution was administered, and the patient was placed
in sitting position for subarachnoid block. After preparing the
site, spinal anaesthesia was successfully performed between L3
and L4 intervertebral space, with a 26-gauge needle and 3 mlFigure 1 MRI showing noof 0.5% hyperbaric bupivacaine (Fig. 3). The patient was
immediately placed in supine position and oxygen was supple-
mented via Hudson’s mask at a flow rate of 6 l/min. After
5 min, the level of anaesthesia was checked and the surgery
was started after 10 min. 1.5 mg of midazolam IV was admin-
istered to sedate the patient.
The surgery lasted for 1 h. All hemodynamic parameters
were stable during the operation. The urinary output was
150 ml. The patient was then shifted to the postoperative
recovery room where he was observed for 3 h and subsequently
shifted to the surgical ward, with no postoperative complica-
tions reported. He was discharged on the 5th postoperative
day.
3. Discussion
Neurofibromatosis is an autosomal dominant disease that has
widespread effects on ectodermal and mesodermal tissue.
Neurofibromatosis-1 (NF1) is the commonest member of the
group which may affect different systems with varying severity.
Neurofibromin, encoded by the gene NF-1 located on chromo-
some 17, is involved in tumour suppression. Inactivation of the
NF-1 gene results in the production of a shortened version ofapparent abnormality.
Figure 2 A photograph of the patient’s back with multiple
neurofibromas.
Figure 3 Local anaesthetic drug being administered through the
spinal route.
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tion and subsequent development of many different types of
tumours seen with the disease. Although neurofibromas are
the characteristic lesions of the disease, they may have wide-
spread effects on the airway, respiratory system, cardiovascu-
lar system, central nervous system, gastrointestinal and
genitourinary system.
Intra-oral manifestations may be seen in approximately 5%
of patients [4]. Distinct lesions may affect the tongue [5,6] and
larynx [7,8], and may also be found in the cervical region and
parapharyngeal space. These may cause obstruction and dis-
tortion of the airway, both prior to or after induction of anaes-
thesia. The difficulty with laryngoscopy and intubation
encountered may require emergency tracheostomy. So,
preoperative evaluation should involve imaging with indirect
laryngoscopy or CT or MRI. In addition, the presence of
macroglossia, macrocephaly, specific mandibular abnormali-
ties [9] and cervical spine involvement may contribute to diffi-
culties of airway management.
Neurofibromas originating from the mediastinum or those
spreading from the retroperitoneum may cause tracheal or
bronchial compression [10]. Though rare, intrapulmonary
neurofibromas may be associated with cough and dyspnoea.
Pulmonary fibrosis may be associated in up to 10–20% of cases
with NF-1 [11]. The pulmonary fibrosis is usually of adult
onset and progressive, [12,13] and may culminate in pul-
monary hypertension and right ventricular failure [14]. Spinal
deformities such as kyphosis and scoliosis with rotation canoccur resulting in reduction in lung volume or even respiratory
failure in severe cases. Hence a detailed evaluation of
respiratory system preoperatively is essential and should
include a chest X-ray, a CT scan of the thorax and detailed
lung function testing.
Hypertension occurs in approximately 6% of NF-1 patients
and in 30% of these cases, it is secondary to renovascular dis-
ease, coarctation of aorta or phaeochromocytoma [15]. In
hypertension present in young NF-1 patients, it is usually
because of renal artery stenosis [16]. Phaeochromocytoma
affects between 0.1% and 5.7% of patients with NF1 but
almost 25% of patients with phaeochromocytoma have the
disease [17]. Vascular neurofibromatosis is seen in some cases
and it may be a cause of aortic and cerebral aneurysms [18].
Superior Vena Obstruction may occur due to large mediastinal
tumours [10]. Clearly, a detailed clinical history coupled with
relevant investigations is must in preoperative assessment of
the cardiovascular system. Regular arterial blood pressure
monitoring should be mandatory in all NF-1 patients and
any anti-hypertensives that are nephrotoxic must be prescribed
with caution. Urinary catecholamine estimation and abdomi-
nal CT scan should be performed if there is any suspicion of
Phaeochromocytoma.
A large part of the morbidity and mortality of NF-1 is
accounted for by tumours of the central nervous system.
Anaesthetic assessment should include history of seizures,
headaches, compressive symptoms and others that may suggest
undiagnosed CNS tumours. An MRI and CT scan of the head
and spine should be made mandatory.
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patients with neurofibroma thus requires careful considera-
tion. Traditionally, general anaesthesia has been the usual
approach as coexisting cranial or spinal neuromas might wor-
sen neurological outcome in patients who have been adminis-
tered for regional anaesthesia. However, associated airway
abnormalities, cardiovascular, central nervous system and
other anomalies make general anaesthesia more risky.
Management of the patients with neurofibroma at the back
poses a challenge to the anaesthesiologist. Decision between
regional and general anaesthesia should also be meticulously
weighed. The identification of the spinous process at the back
is quite difficult but not impossible by an experienced
anaesthesiologist.
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